1. Homepage
  2. Equities
  3. Australia
  4. Australian Stock Exchange
  5. Patrys Limited
  6. News
  7. Summary
    PAB   AU000000PAB9

PATRYS LIMITED

(PAB)
Delayed Australian Stock Exchange  -  02:10 2022-08-10 am EDT
0.0260 AUD   +8.33%
04:10aPatrys Validates Efficacy of Brain Cancer Drug in Preclinical Animal Study
MT
08/07Patrys Chair to Retire End-August
MT
07/27PATRYS : Appendix 4C - Quarterly - 30 June 2022
PU
SummaryQuotesChartsNewsCalendarCompanyFinancials 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

Patrys : Application for quotation of securities - PAB

02/07/2022 | 06:51pm EDT

Application for quotation of +securities

Announcement Summary

For personal use only

Entity name

PATRYS LIMITED

Announcement Type

New announcement

Date of this announcement

Tuesday February 08, 2022

The +securities to be quoted are:

+Securities issued, transferred or re-classified as a result of options being exercised or other +convertible securities being converted

Total number of +securities to be quoted

ASX +security

Number of +securities to

code

Security description

be quoted

Issue date

PAB

ORDINARY FULLY PAID

27,248

08/02/2022

Refer to next page for full details of the announcement

Application for quotation of +securities

1 / 6

Application for quotation of +securities

Part 1 - Entity and announcement details

For personal use only

1.1 Name of entity

PATRYS LIMITED

We (the entity named above) apply for +quotation of the following +securities and agree to the matters set out in Appendix 2A of the ASX Listing Rules.

1.2

Registered number type

Registration number

ABN

97123055363

1.3

ASX issuer code

PAB

  1. The announcement is New announcement
  2. Date of this announcement

8/2/2022

Application for quotation of +securities

2 / 6

Application for quotation of +securities

Part 2 - Type of Issue

For personal use only

2.1 The +securities to be quoted are:

+Securities issued, transferred or re-classified as a result of options being exercised or other +convertible securities being converted

2.2 The +securities to be quoted are:

Additional +securities in a class that is already quoted on ASX ("existing class")

Application for quotation of +securities

3 / 6

Application for quotation of +securities

Part 3B - number and type of +securities to be quoted (existing class) where issue has not previously been notified to ASX in an Appendix 3B

only

Existing +securities converting into additional +securities in an existing class

FROM (Existing Class)

ASX +security code and description

PABO : OPTION EXPIRING 05-AUG-2023

use

TO (Existing Class)

ASX +security code and description

PAB : ORDINARY FULLY PAID

Please state the number of options that were exercised or other +convertible securities that were converted

27,248

The first date the options were exercised or other +convertible securities were converted

The last date the options were exercised or other +convertible securities were converted

8/2/2022

For personal

Is this all of the options or other +convertible securities on issue of that type (ie have all of those options now been exercised or have all of those convertible securities now been converted)?

No

The right of the holder of the options or other +convertible securities to receive the +underlying securities is being satisfied by:

An issue of new +securities

The underlying securities being received by the holder are:

Intended to be, but are not yet, quoted by ASX

Were the options being exercised or other +convertible securities being converted issued under an +employee incentive scheme?

No

Issue date

8/2/2022

Will the +securities to be quoted rank equally in all respects from their issue date with the existing issued +securities in that class?

Yes

Application for quotation of +securities

4 / 6

Application for quotation of +securities

Issue details

Number of +securities to be quoted

27,248

For personal use only

Are the +securities being issued for a cash consideration?

Yes

In what currency is the cash consideration being paid? What is the issue price per +security?

AUD - Australian Dollar

AUD 0.02400000

Any other information the entity wishes to provide about the +securities to be quoted

Application for quotation of +securities

5 / 6

This is an excerpt of the original content. To continue reading it, access the original document here.

Disclaimer

Patrys Limited published this content on 07 February 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 07 February 2022 23:50:02 UTC.


© Publicnow 2022
All news about PATRYS LIMITED
04:10aPatrys Validates Efficacy of Brain Cancer Drug in Preclinical Animal Study
MT
08/07Patrys Chair to Retire End-August
MT
07/27PATRYS : Appendix 4C - Quarterly - 30 June 2022
PU
07/04Patrys Produces Antibody Drug at Commercial Scale
MT
07/03Patrys Limited Announces Successful Completion of Pat-Dx1 Engineering Run
CI
06/14Patrys Identifies New Mechanism of Action for Anti-Cancer Antibody
MT
06/03Patrys Secures Grant Funding to Develop Brain Cancer Drug
MT
04/27PATRYS : Appendix 4C - Quarterly - 31 March 2022
PU
04/14PATRYS : Application for quotation of securities - PAB
PU
03/23NEW RESEARCH : Scientists determine structure of a DNA damage ‘First Responder' prot..
PU
More news
Financials
Sales 2021 1,34 M 0,93 M 0,93 M
Net income 2021 -4,06 M -2,83 M -2,83 M
Net cash 2021 10,9 M 7,61 M 7,61 M
P/E ratio 2021 -22,2x
Yield 2021 -
Capitalization 49,4 M 34,4 M 34,4 M
EV / Sales 2020 11,5x
EV / Sales 2021 67,8x
Nbr of Employees 10
Free-Float 70,9%
Chart PATRYS LIMITED
Duration : Period :
Patrys Limited Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends PATRYS LIMITED
Short TermMid-TermLong Term
TrendsBullishNeutralBearish
Income Statement Evolution
Managers and Directors
James A. Campbell Chief Executive Officer, MD & Director
John Douglas Read Non-Executive Chairman
Valentina Dubljevic Vice President-Scientific & Clinical Development
Michael J. Stork Deputy Chairman & Non-Executive Director
Suzy Jones Non-Executive Director
Sector and Competitors
1st jan.Capi. (M$)
PATRYS LIMITED-35.14%34
MODERNA, INC.-32.62%66 950
LONZA GROUP AG-26.76%43 416
IQVIA HOLDINGS INC.-17.56%43 382
SEAGEN INC.13.58%32 387
ALNYLAM PHARMACEUTICALS, INC.31.72%26 810